IVERS-READ GILLIAN C (See Remarks) sold 1.3% of their position (3.80K shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $5.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/3/2022ACC: 0000899243-22-027576
Officer· See Remarks
Since Sep 2018
-3.80K
Net shares
Net seller
$5.6K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
8.37K acquired · 12.18K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3.75K
Price / share
—
Trade value
—
% of position
1.3%
8/1/2022
281.52K→285.27K
Common Stock
Direct
Shares
+4.63K
Price / share
—
Trade value
—
% of position
1.6%
8/1/2022
283.56K→288.19K
Common Stock
Direct
Shares
−1.70K
Price / share
$1.46
Trade value
$2.49K
% of position
0.6%
8/2/2022
285.27K→283.56K
Common Stock
Direct
Shares
−2.10K
Price / share
$1.46
Trade value
$3.07K
% of position
0.7%
8/2/2022
288.19K→286.09K
Total
Net shares
+4.57K
Net value
-$5.55K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/1/2022 | M · Option Exercise | +3.75K | — | — | 1.3% | 281.52K | 285.27K |
| Common Stock Direct | 8/1/2022 | M · Option Exercise | +4.63K | — | — | 1.6% | 283.56K | 288.19K |
| Common Stock Direct | 8/2/2022 | S · Sale | −1.70K | $1.46 | $2.49K | 0.6% | 285.27K | 283.56K |
| Common Stock Direct | 8/2/2022 | S · Sale | −2.10K | $1.46 | $3.07K | 0.7% | 288.19K | 286.09K |
| Total | +4.57K | -$5.55K | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
3.75K shares
Shares
−3.75K
Strike price
Held after
7.50K
Exercisable
—
8/1/2022
Restricted Stock Units
Direct
Converts to
Common Stock
4.63K shares
Shares
−4.63K
Strike price
Held after
27.75K
Exercisable
—
8/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock3.75K shares | 8/1/2022 | M · Option Exercise | −3.75K | — | 7.50K | |
| Restricted Stock Units Direct | Common Stock4.63K shares | 8/1/2022 | M · Option Exercise | −4.63K | — | 27.75K |